FI970786A0 - 4-(2-amino-6-(cyklopropylamino)-9H-purin-9-yl)-2-cyklopenten-1-metanolsuccinat som antivirala ämnen - Google Patents

4-(2-amino-6-(cyklopropylamino)-9H-purin-9-yl)-2-cyklopenten-1-metanolsuccinat som antivirala ämnen

Info

Publication number
FI970786A0
FI970786A0 FI970786A FI970786A FI970786A0 FI 970786 A0 FI970786 A0 FI 970786A0 FI 970786 A FI970786 A FI 970786A FI 970786 A FI970786 A FI 970786A FI 970786 A0 FI970786 A0 FI 970786A0
Authority
FI
Finland
Prior art keywords
purin
cyclopropylamino
amino
cyclopenten
antiviral agents
Prior art date
Application number
FI970786A
Other languages
English (en)
Finnish (fi)
Other versions
FI970786A (sv
FI120403B (sv
Inventor
Susan Mary Daluge
Jeffrey Douglas Wilson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI970786A publication Critical patent/FI970786A/sv
Publication of FI970786A0 publication Critical patent/FI970786A0/sv
Application granted granted Critical
Publication of FI120403B publication Critical patent/FI120403B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
FI970786A 1994-08-26 1997-02-25 4-(2-amino-6-(cyklopropylamino)-9H-purin-9-yl)-2-cyklopenten-1-metanolsuccinat som antivirala ämnen FI120403B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9417249A GB9417249D0 (en) 1994-08-26 1994-08-26 A novel salt
GB9417249 1994-08-26
PCT/GB1995/002014 WO1996006844A1 (en) 1994-08-26 1995-08-25 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent
GB9502014 1995-08-25

Publications (3)

Publication Number Publication Date
FI970786A FI970786A (sv) 1997-02-25
FI970786A0 true FI970786A0 (sv) 1997-02-25
FI120403B FI120403B (sv) 2009-10-15

Family

ID=10760434

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970786A FI120403B (sv) 1994-08-26 1997-02-25 4-(2-amino-6-(cyklopropylamino)-9H-purin-9-yl)-2-cyklopenten-1-metanolsuccinat som antivirala ämnen

Country Status (23)

Country Link
EP (1) EP0777669B1 (sv)
JP (1) JPH10505593A (sv)
KR (1) KR100376240B1 (sv)
CN (1) CN1051550C (sv)
AT (1) ATE220067T1 (sv)
AU (1) AU702618B2 (sv)
BR (1) BR9508629A (sv)
CA (1) CA2198010C (sv)
DE (1) DE69527294T2 (sv)
DK (1) DK0777669T3 (sv)
ES (1) ES2179110T3 (sv)
FI (1) FI120403B (sv)
GB (1) GB9417249D0 (sv)
HU (1) HU221302B1 (sv)
IL (1) IL115074A (sv)
MX (1) MX9701273A (sv)
NO (1) NO315200B1 (sv)
NZ (1) NZ291862A (sv)
PT (1) PT777669E (sv)
RU (1) RU2145324C1 (sv)
SI (1) SI0777669T1 (sv)
WO (1) WO1996006844A1 (sv)
ZA (1) ZA957166B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
BR9809127A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
JP2001525840A (ja) * 1997-05-17 2001-12-11 グラクソ、グループ、リミテッド 炭素環式ヌクレオシド１５９２ｕ８９を含有する抗ウイルス的組合せ
CZ299083B6 (cs) * 1997-11-27 2008-04-16 Lonza Ag Zpusob výroby aminoalkoholu
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
WO2003011221A2 (en) 2001-07-30 2003-02-13 University Of Southern California PREPARATION AND USE OF α-KETO PHOSPHONATES
NZ546447A (en) * 2003-10-27 2009-02-28 Merck & Co Inc ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine succinate
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
US9650346B2 (en) 2011-04-08 2017-05-16 Laurus Labs Private Ltd. Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
JP6391561B2 (ja) 2013-02-27 2018-09-19 国立大学法人京都大学 がんの予防または治療用医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025492A1 (de) * 1980-07-04 1982-02-04 Siemens AG, 1000 Berlin und 8000 München Filterelement fuer die optische nachrichtentechnik
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Also Published As

Publication number Publication date
KR970705563A (ko) 1997-10-09
DK0777669T3 (da) 2002-10-28
ZA957166B (en) 1997-02-25
DE69527294T2 (de) 2003-02-13
CN1051550C (zh) 2000-04-19
KR100376240B1 (ko) 2003-06-11
CA2198010C (en) 2006-05-02
CN1156456A (zh) 1997-08-06
NO315200B1 (no) 2003-07-28
GB9417249D0 (en) 1994-10-19
EP0777669A1 (en) 1997-06-11
AU3350995A (en) 1996-03-22
FI970786A (sv) 1997-02-25
CA2198010A1 (en) 1996-03-07
NO970847D0 (no) 1997-02-25
FI120403B (sv) 2009-10-15
BR9508629A (pt) 1997-11-25
HUT77222A (hu) 1998-03-02
NZ291862A (en) 1998-02-26
NO970847L (no) 1997-02-25
IL115074A0 (en) 1995-12-08
ES2179110T3 (es) 2003-01-16
DE69527294D1 (en) 2002-08-08
RU2145324C1 (ru) 2000-02-10
ATE220067T1 (de) 2002-07-15
HU221302B1 (en) 2002-09-28
EP0777669B1 (en) 2002-07-03
SI0777669T1 (en) 2002-12-31
JPH10505593A (ja) 1998-06-02
MX9701273A (es) 1997-05-31
AU702618B2 (en) 1999-02-25
WO1996006844A1 (en) 1996-03-07
PT777669E (pt) 2002-11-29
IL115074A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
TW371660B (en) Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
WO1998056761A3 (en) Benzimidazole derivatives
MY117892A (en) Therapeutic compounds
MY104043A (en) Therapeutic nucleosides.
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
FI970786A (sv) 4-(2-amino-6-(cyklopropylamino)-9H-purin-9-yl)-2-cyklopenten-1-metanolsuccinat som antivirala ämnen
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
HUP0002754A2 (hu) (1S,4R)-cisz-4-[2-amino-6-(ciklopropil-amino)-9H-purin-9-il]-2-ciklopentén-1-metanol-hemiszulfát, eljárás előállítására, ezt tartalmazó gyógyszerkészítmény, valamint intermedierek
MX9805441A (es) Compuestos terapeuticos.
AU643987B2 (en) Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
HK1012238A1 (en) Use of benzimidazole anthelmintic in the treatment of microsporidial infections
GR960300005T1 (en) Extracts of piliostigma thonningii, the use thereof and formulations containing them.
ES2078380T3 (es) Oligofosfatos de accion antiviral.
ECSP993155A (es) Compuestos quimicos

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120403

Country of ref document: FI

MA Patent expired